Question 1

How many shares of BCRX does STIFEL FINANCIAL CORP own?

Accepted Answer

As of 2026-Q2, STIFEL FINANCIAL CORP holds 1.8M shares of BCRX (BIOCRYST PHARMACEUTICALS INC).

Question 2

What is STIFEL FINANCIAL CORP's BCRX position worth?

Accepted Answer

As of 2026-Q2, STIFEL FINANCIAL CORP's BCRX position is worth $18.3M.

Question 3

Is STIFEL FINANCIAL CORP buying or selling BCRX?

Accepted Answer

In 2026-Q2, STIFEL FINANCIAL CORP increased their BCRX position (+0.1% change in shares).

Question 4

When did STIFEL FINANCIAL CORP first buy BCRX?

Accepted Answer

Based on available 13F filings, STIFEL FINANCIAL CORP first reported a position in BCRX in 2024-Q3. They have held the position across 26 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	1.8M	+0.1%	$18.3M	0.0%	$10.00	28
2026-Q1	Increased	1.8M	+0.0%	$17.4M	0.0%	$9.52	28
2025-Q4	Increased	1.8M	+0.1%	$14.2M	0.0%	$7.80	28
2025-Q3	Decreased	1.8M	-0.0%	$13.8M	0.0%	$7.59	0
2025-Q2	Decreased	1.8M	-0.8%	$16.3M	0.0%	$8.96	0
2025-Q1	Decreased	1.8M	-0.3%	$13.8M	0.0%	$7.50	0
2024-Q4	Decreased	1.8M	-0.0%	$13.9M	0.0%	$7.52	0
2024-Q3	Decreased	1.8M	-0.0%	$14M	0.0%	$7.60	0